An improved synthesis of the C-linked glucuronide of N-(4-hydroxyphenyl)retinamide

Bioorg Med Chem Lett. 2002 Sep 2;12(17):2447-50. doi: 10.1016/s0960-894x(02)00427-4.

Abstract

Retinoic acid analogues such as N-(4-hydroxyphenyl)retinamide (4-HPR) are effective chemopreventatives and chemotherapeutics for numerous types of cancer. The C-linked analogue of the O-glucuronide of 4-HPR (4-HPRCG) has been shown to be a more effective agent. The synthetic route to this molecule has been significantly improved by access to a key C-benzyl-glucuronide intermediate through employment of a Suzuki coupling reaction between an exoanomeric methylene sugar and an aryl bromide. Preliminary evidence shows 4-HPRCG has chemotherapeutic activity.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Fenretinide / chemical synthesis*
  • Fenretinide / pharmacology
  • Glucuronides / chemical synthesis*
  • Glucuronides / pharmacology
  • Mammary Neoplasms, Experimental / drug therapy
  • Mammary Neoplasms, Experimental / prevention & control
  • Protein Binding
  • Rats
  • Receptors, Retinoic Acid / metabolism
  • Retinoids / chemical synthesis
  • Retinoids / pharmacology

Substances

  • Antineoplastic Agents
  • Glucuronides
  • Receptors, Retinoic Acid
  • Retinoids
  • Fenretinide